Skip to main content
Veterinary Medicines

ORBESEAL DRY COW 2.6G INTRAMAMMARY SUSPENSION

Authorised
  • Bismuth subnitrate, heavy

Product identification

Medicine name:
ORBESEAL DRY COW 2.6G INTRAMAMMARY SUSPENSION
Orbeseal vet. 2,6 g intramammarie, suspensjon til sinkyr
Active substance:
  • Bismuth subnitrate, heavy
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Bismuth subnitrate, heavy
    2.60
    gram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG52X
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Boxes of 60 syringes
  • Plastic bucket of 120 syringes
  • Boxe of 24 syringes

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cross Vetpharm Group Limited
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Norwegian Medicines Agency
Authorisation number:
  • 02-1548
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0341/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Denmark
  • Finland
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 6/06/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 6/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."